FMRI response to negative words and SSRI treatment outcome in major depressive disorder: A preliminary study

Psychiatry Research - Neuroimaging

Volumn 214, Issue 3, 2013, Pages 296-305

  Miller, Jeffrey Morris ^a,b   Schneck, Noam ^a,c   Siegle, Greg J ^d   Chen, Yakuan ^e   Ogden, R Todd ^a,e   Kikuchi, Toshiaki ^a,f   Oquendo, Maria A ^a,b   Mann, J John ^a,b   Parsey, Ramin V ^g  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c FAIRLEIGH DICKINSON UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e Department of Medicine   (United States)

^f KEIO UNIVERSITY   (Japan)

^g STONY BROOK UNIVERSITY   (United States)

Author keywords

Biomarker; FMRI; Major depressive disorder; Prediction; SSRI; Treatment outcome

Indexed keywords

ESCITALOPRAM;

ADULT; ANTERIOR CINGULATE; ARTICLE; BOLD SIGNAL; CAUDATE NUCLEUS; CLINICAL ARTICLE; EXECUTIVE FUNCTION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MAJOR DEPRESSION; MALE; MESENCEPHALON; OCCIPITAL CORTEX; POSTERIOR CINGULATE; PREFRONTAL CORTEX; PRIORITY JOURNAL; THALAMUS; TREATMENT OUTCOME; TREATMENT RESPONSE; WORD RECOGNITION;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; BRAIN; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; EMOTIONS; FEMALE; HUMANS; LANGUAGE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROIMAGING; REACTION TIME; REPRODUCIBILITY OF RESULTS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84888289796     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2013.08.001     Document Type: Article

References (51)

1. Alexopoulos G.S., Hoptman M.J., Yuen G., Kanellopoulos D., Seirup J.K., Lim K.O., Gunning F.M. Functional connectivity in apathy of late-life depression: a preliminary study. Journal of Affective Disorders 2012.
2. Anderson I.M., Juhasz G., Thomas E., Downey D., McKie S., Deakin J.F.W., Elliott R. The effect of acute citalopram on face emotion processing in remitted depression: a pharmacoMRI study. European Neuropsychopharmacology 2011, 21:140-148.
3. Avants B.B., Tustison N.J., Wu J., Cook P.A., Gee J.C. An open source multivariate framework for n-tissue segmentation with evaluation on public data. Neuroinformatics 2011, 9:381-400.
4. Beauregard M., Levesque J., Bourgouin P. Neural correlates of conscious self-regulation of emotion. Journal of Neuroscience 2001, 21:RC165.
5. Blier P., De Montigny C. Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat. Journal of Neuroscience 1983, 3:1270-1278.
6. Chan S.W.Y., Norbury R., Goodwin G.M., Harmer C.J. Risk for depression and neural responses to fearful facial expressions of emotion. British Journal of Psychiatry 2009, 194:139-145.
7. Chen C.H., Ridler K., Suckling J., Williams S., Fu C.H., Merlo-Pich E., Bullmore E. Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biological Psychiatry 2007, 62:407-414.
8. Davidson R.J., Irwin W., Anderle M.J., Kalin N.H. The neural substrates of affective processing in depressed patients treated with venlafaxine. American Journal of Psychiatry 2003, 160:64-75.
9. Dichter G.S., Felder J.N., Smoski M.J. The effects of brief behavioral activation therapy for depression on cognitive control in affective contexts: an fMRI investigation. Journal of Affective Disorders 2010, 126:236-244.
10. Elliott R., Zahn R., Deakin J.F.W., Anderson I.M. Affective cognition and its disruption in mood disorders. Neuropsychopharmacology 2011, 36:153-182.
11. Fales C.L., Barch D.M., Rundle M.M., Mintun M.A., Mathews J., Snyder A.Z., Sheline Y.I. Antidepressant treatment normalizes hypoactivity in dorsolateral prefrontal cortex during emotional interference processing in major depression. Journal of Affective Disorders 2009, 112:206-211.
12. First, M., Spitzer, R., Gibbon, M., Williams, J., 1995. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I/P, Version 2.0). Biometrics Research Department, New York State, Psychiatric Institute, New York.
13. Fu C.H., Williams S.C., Cleare A.J., Brammer M.J., Walsh N.D., Kim J., Andrew C.M., Pich E.M., Williams P.M., Reed L.J., Mitterschiffthaler M.T., Suckling J., Bullmore E.T. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Archives of General Psychiatry 2004, 61:877-889.
14. Fu C.H., Williams S.C., Cleare A.J., Scott J., Mitterschiffthaler M.T., Walsh N.D., Donaldson C., Suckling J., Andrew C., Steiner H., Murray R.M. Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biological Psychiatry 2008, 64:505-512.
15. Gerber A.J., Posner J., Gorman D., Colibazzi T., Yu S., Wang Z., Kangarlu A., Zhu H., Russell J., Peterson B.S. An affective circumplex model of neural systems subserving valence, arousal, and cognitive overlay during the appraisal of emotional faces. Neuropsychologia 2008, 46:2129-2139.
16. Grinband J., Wager T.D., Lindquist M., Ferrera V.P., Hirsch J. Detection of time-varying signals in event-related fMRI designs. Neuroimage 2008, 43:509-520.
17. Grunebaum M.F., Keilp J., Li S., Ellis S.P., Burke A.K., Oquendo M.A., Mann J.J. Symptom components of standard depression scales and past suicidal behavior. Journal of Affective Disorders 2005, 87:73-82.
18. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960, 23:56-62.
19. Harmer C.J., Goodwin G.M., Cowen P.J. Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. British Journal of Psychiatry 2009, 195:102-108.
20. Harmer C.J., Mackay C.E., Reid C.B., Cowen P.J., Goodwin G.M. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biological Psychiatry 2006, 59:816-820.
21. Harmer C.J., O'Sullivan U., Favaron E., Massey-Chase R., Ayres R., Reinecke A., Goodwin G.M., Cowen P.J. Effect of acute antidepressant administration on negative affective bias in depressed patients. American Journal of Psychiatry 2009, 166:1178-1184.
22. Jasinska A.J., Lowry C.A., Burmeister M. Serotonin transporter gene, stress and raphe-raphe interactions: a molecular mechanism of depression. Trends in Neurosciences 2012, 35:395-402.
23. Jenkinson M., Bannister P., Brady M., Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002, 17:825-841.
24. Joormann J., Gotlib I.H. Emotion regulation in depression: relation to cognitive inhibition. Cognition and Emotion 2010, 24:281-298.
25. Keedwell P.A., Drapier D., Surguladze S., Giampietro V., Brammer M., Phillips M. Subgenual cingulate and visual cortex responses to sad faces predict clinical outcome during antidepressant treatment for depression{star, open}. Journal of Affective Disorders 2010, 120:120-125.
26. Kemp A.H., Gordon E., Rush A.J., Williams L.M. Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures. CNS Spectrums 2008, 13:1066-1086.
27. Kennedy S.H., Konarski J.Z., Segal Z.V., Lau M.A., Bieling P.J., McIntyre R.S., Mayberg H.S. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. American Journal of Psychiatry 2007, 164:778-788.
28. Kikuchi T., Miller J.M., Schneck N., Oquendo M.A., Mann J.J., Parsey R.V., Keilp J.G. Neural responses to incongruency in a blocked-trial Stroop fMRI task in major depressive disorder. Journal of Affective Disorders 2012, 143:241-247.
29. Konarski J.Z., Kennedy S.H., Segal Z.V., Lau M.A., Bieling P.J., McIntyre R.S., Mayberg H.S. Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. Journal of Psychiatry and Neuroscience 2009, 34:175-180.
30. Langenecker S.A., Kennedy S.E., Guidotti L.M., Briceno E.M., Own L.S., Hooven T., Young E.A., Akil H., Noll D.C., Zubieta J.K. Frontal and limbic activation during inhibitory control predicts treatment response in major depressive disorder. Biological Psychiatry 2007, 62:1272-1280.
31. Mayberg H.S. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. British Medical Bulletin 2003, 65:193-207.
32. Mayberg H.S., Brannan S.K., Mahurin R.K., Jerabek P.A., Brickman J.S., Tekell J.L., Silva J.A., McGinnis S., Glass T.G., Martin C.C., Fox P.T. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997, 8:1057-1061.
33. Mayberg H.S., Brannan S.K., Tekell J.L., Silva J.A., Mahurin R.K., McGinnis S., Jerabek P.A. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biological Psychiatry 2000, 48:830-843.
34. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., Silva J.A., Tekell J.L., Martin C.C., Lancaster J.L., Fox P.T. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. American Journal of Psychiatry 1999, 156:675-682.
35. Miller J.M., Vorel S.R., Tranguch A.J., Kenny E.T., Mazzoni P., van Gorp W.G., Kleber H.D. Anhedonia after a selective bilateral lesion of the globus pallidus. American Journal of Psychiatry 2006, 163:786-788.
36. Murphy S.E., Yiend J., Lester K.J., Cowen P.J., Harmer C.J. Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers. International Journal of Neuropsychopharmacology 2009, 12:169-179.
37. Ochsner K.N., Gross J.J. The cognitive control of emotion. Trends in Cognitive Science 2005, 9:242-249.
38. Olafsson R.P., Smari J., Guethmundsdottir F., Olafsdottir G., Harethardottir H.L., Einarsson S.M. Self reported attentional control with the attentional control scale: factor structure and relationship with symptoms of anxiety and depression. Journal of Anxiety Disorders 2011, 25:777-782.
39. Pizzagalli D., Pascual-Marqui R.D., Nitschke J.B., Oakes T.R., Larson C.L., Abercrombie H.C., Schaefer S.M., Koger J.V., Benca R.M., Davidson R.J. Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. American Journal of Psychiatry 2001, 158:405-415.
40. Pizzagalli D.A. Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology 2011, 36:183-206.
41. Ruhe H.G., Booij J., Veltman D.J., Michel M.C., Schene A.H. Successful pharmacologic treatment of major depressive disorder attenuates amygdala activation to negative facial expressions: a functional magnetic resonance imaging study. Journal of Clinical Psychiatry 2012, 73:451-459.
42. Siegle G.J., Carter C.S., Thase M.E. Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy. American Journal of Psychiatry 2006, 163:735-738.
43. Siegle G.J., Thompson W.K., Collier A., Berman S.R., Feldmiller J., Thase M.E., Friedman E.S. Toward clinically useful neuroimaging in depression treatment: prognostic utility of subgenual cingulate activity for determining depression outcome in cognitive therapy across studies, scanners, and patient characteristics. Archives of General Psychiatry 2012, 69:913-924.
44. Smith S.M. Fast robust automated brain extraction. Human Brain Mapping 2002, 17:143-155.
45. Vataja R., Leppavuori A., Pohjasvaara T., Mantyla R., Aronen H.J., Salonen O., Kaste M., Erkinjuntti T. Poststroke depression and lesion location revisited. Journal of Neuropsychiatry and Clinical Neurosciences 2004, 16:156-162.
46. Victor T.A., Furey M.L., Fromm S.J., Ohman A., Drevets W.C. Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder. Archives of General Psychiatry 2010, 67:1128-1138.
47. Vul E., Harris C., Winkielman P., Pashler H. Puzzlingly high correlations in fmri studies of emotion, personality, and social cognition. Perspectives on Psychological Science 2009, 4:17.
48. Walsh N.D., Williams S.C.R., Brammer M.J., Bullmore E.T., Kim J., Suckling J., Mitterschiffthaler M.T., Cleare A.J., Pich E.M., Mehta M.A., Fu C.H.Y. A longitudinal functional magnetic resonance imaging study of verbal working memory in depression after antidepressant therapy. Biological Psychiatry 2007, 62:1236-1243.
49. Witt S.T., Stevens M.C. Overcoming residual interference in mental set switching: neural correlates and developmental trajectory. Neuroimage 2012, 62:2055-2064.
50. Worsley, K.J., 2001. Statistical analysis of activation images, In: Jezzard P., Mathews P.M., Smith. S.M. (Eds.), Functional MRI: An Introduction to Methods. OUP.
51. Zhang X., Yaseen Z.S., Galynker I.I., Hirsch J., Winston A. Can depression be diagnosed by response to mother's face? A personalized attachment-based paradigm for diagnostic fMRI. PLoS One 2011, 6:e27253.